Current through all regulations passed and filed through September 16, 2024
Pursuant to section
3719.41 of the Revised Code,
controlled substance schedule II is hereby established, which schedules include
the following, subject to amendment pursuant to section
3719.43 or
3719.44 of the Revised
Code.
(A)
Narcotics-opium and opium derivatives
Unless specifically excepted under
federal drug abuse control laws or unless listed in another schedule, any of
the following substances whether produced directly or indirectly by extraction
from substances of vegetable origin, independently by means of chemical
synthesis, or by a combination of extraction and chemical
synthesis:
(1)
Opium and opiate, and any salt, compound, derivative,
or preparation of opium or opiate excluding apomorphine, thebaine-derived
butorphanol, dextrorphan, nalbuphine, naldemedine, nalmefene, naloxegol,
naloxone, and naltrexone, and their respective salts, but including the
following:
(a)
Raw opium;
(b)
Opium
extracts;
(c)
Opium fluid extracts;
(d)
Powdered
opium;
(e)
Granulated opium;
(f)
Tincture of
opium;
(g)
Codeine;
(h)
Dihydroetorphine;
(i)
Ethylmorphine;
(j)
Etorphine
hydrochloride;
(k)
Hydrocodone;
(l)
Hydromorphone;
(m)
Metopon;
(n)
Morphine;
(o)
Noroxymorphone;
(p)
Oripavine;
(q)
Oxycodone;
(r)
Oxymorphone;
(s)
Thebaine.
(2)
Any salt,
compound, derivative, or preparation thereof that is chemically equivalent to
or identical with any of the substances referred to in paragraph (A)(1) of this
rule, except that these substances shall not include the isoquinoline alkaloids
of opium;
(3)
Opium poppy and poppy straw;
(4)
Coca leaves and
any salt, compound, derivative, or preparation of coca leaves (including
cocaine and ecgonine, their salts, isomers, and derivatives, and salts of those
isomers and derivatives), and any salt, compound, derivative, or preparation
thereof that is chemically equivalent to or identical with any of these
substances, except that the substances shall not include:
(a)
Decocainized coca
leaves or extraction of coca leaves, which extractions do not contain cocaine
or ecgonine; or
(b)
[123I]ioflupane.
(5)
Concentrate of
poppy straw (the crude extract of poppy straw in either liquid, solid, or
powder form that contains the phenanthrene alkaloids of the opium poppy).
(B)
Narcotics-opiates
Unless specifically excepted under
federal drug abuse control laws or unless listed in another schedule, any of
the following opiates, including their isomers, esters, ethers, salts, and
salts of isomers, esters, and ethers, whenever the existence of these isomers,
esters, ethers, and salts is possible within the specific chemical designation,
but excluding dextrorphan and levopropoxyphene:
(1)
Alfentanil;
(2)
Alphaprodine;
(3)
Anileridine;
(4)
Bezitramide;
(5)
Bulk
dextropropoxyphene (non-dosage forms);
(6)
Carfentanil;
(7)
Dihydrocodeine;
(8)
Diphenoxylate;
(9)
Fentanyl;
(10)
Isomethadone;
(11)
Levo-alphacetylmethadol (some other names:
levo-alpha-acetylmethadol; levomethadyl acetate; LAAM);
(12)
Levomethorphan;
(13)
Levorphanol;
(14)
Metazocine;
(15)
Methadone;
(16)
Methadone-intermediate, 4-cyano-2-dimethylamino-4,4-diphenyl
butane;
(17)
Moramide-intermediate,
2-methyl-3-morpholino-1,1-diphenylpropane-carboxylic acid;
(18)
Pethidine
(meperidine);
(19)
Pethidine-intermediate-A,
4-cyano-1-methyl-4-phenylpiperidine;
(20)
Pethidine-intermediate-B,
ethyl-4-phenylpiperidine-4-carboxylate;
(21)
Pethidine-intermediate-C,
1-methyl-4-phenylpiperidine-4-carboxylic acid;
(22)
Phenazocine;
(23)
Piminodine;
(24)
Racemethorphan;
(25)
Racemorphan;
(26)
Remifentanil;
(27)
Sufentanil;
(28)
Tapentadol;
(29)
Thiafentanil.
(C)
Stimulants
Unless specifically excepted under
federal drug abuse control laws or unless listed in another schedule, any
material, compound, mixture, or preparation that contains any quantity of the
following substances having a stimulant effect on the central nervous
system:
(1)
Amphetamine, its salts, its optical isomers, and salts
of its optical isomers;
(2)
Methamphetamine, its salts, its isomers, and salts of
its isomers;
(3)
Methylphenidate;
(4)
Phenmetrazine and
its salts;
(5)
Lisdexamfetamine, its salts, isomers, and salts of its
isomers.
(D)
Depressants
Unless specifically excepted under
federal drug abuse control laws or unless listed in another schedule, any
material, compound, mixture, or preparation that contains any quantity of the
following substances having a depressant effect on the central nervous system,
including their salts, isomers, and salts of isomers, whenever the existence of
these salts, isomers, and salts of isomers is possible within the specific
chemical designation:
(1)
Amobarbital;
(2)
Glutethimide;
(3)
Pentobarbital;
(4)
Phencyclidine
(some trade or other names: 1-(1-phenylcyclohexyl)piperidine;
PCP);
(5)
Secobarbital;
(6)
1-aminophenylcyclohexane and all N-mono-substituted and/or
all N-N-disubstituted analogs including, but not limited to, the
following:
(a)
1-phenylcyclohexylamine;
(b)
(1-phenylcyclohexyl) methylamine;
(c)
(1-phenylcyclohexyl) dimethylamine;
(d)
(1-phenylcyclohexyl) methylethylamine;
(e)
(1-phenylcyclohexyl) isopropylamine;
(f)
1-(1-phenylcyclohexyl)
morpholine.
(E)
Hallucinogenic
substances
(1)
Nabilone (another name for nabilone:
(+)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a- hexahydro-1-
hydroxy-6,6-dimethyl-9H-dibenzo[b,d]pyran-9-one);
(2)
Dronabinol
[(-)-delta-9-trans tetrahydrocannabinol] in an oral solution in a dangerous
drug approved for marketing by the U.S. food and drug
administration.
(F)
Immediate precursors
Unless specifically excepted under
federal drug abuse control laws or unless listed in another schedule, any
material, compound, mixture, or preparation that contains any quantity of the
following substances:
(1)
Immediate precursor to amphetamine and
methamphetamine:
Phenylacetone (some trade or other
names: phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzyl
ketone);
(2)
Immediate precursors to phencyclidine (PCP):
(a)
1-phenylcyclohexylamine;
(b)
1-piperidinocyclohexanecarbonitrile
(PCC).
(3)
Immediate precursor to fentanyl:
4-anilino-N-phenethylpiperidine
(ANPP).
Replaces: 4729-11-03
Effective:
3/22/2020
Five Year Review (FYR) Dates:
03/22/2025
Promulgated
Under: 119.03
Statutory
Authority: 4729.26,
3719.28,
3719.41
Rule
Amplifies: 3719.43,
3719.44
Prior
Effective Dates: 09/01/2014
